Gesynta Pharma AB
ActiveKey figures
Key figures
2025Summary: Gesynta Pharma AB
What kind of company is it?
Gesynta Pharma AB (org. no. 559103-6628) is a limited company (AB). The company was registered in 2017 and has existed for 9 years. Registered seat: Stockholm. Industry according to Statistics Sweden: other research and experimental development on natural sciences and engineering (SNI 72109).
How is the company doing financially?
Net sales in financial year 2025 were 342 933 kr. From 2023 to 2025, net sales grew by an average of 170 % per year. Financial year 2025 ended with a loss of 88 209 803 kr. The company made a loss in all 3 reported financial years. Employees in financial year 2025: 4 (previous year: 3). Net sales per employee were 85 733 kr. At the end of financial year 2025, total assets were 212 804 063 kr and equity 191 725 279 kr (equity ratio 90,1 %).
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by 10 people. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Summary of annual reports2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Sales revenue | 47 000 | 0 | 342 933 |
| Profit for the reporting year | −19 926 821 | −15 224 569 | −88 209 803 |
| Retained earnings of previous periods | — | — | — |
| Total assets | 15 066 000 | 28 170 000 | 212 804 063 |
| Total liabilities | 2 875 753 | 22 329 722 | 21 078 784 |
| Total equity | 12 190 247 | 5 840 278 | 191 725 279 |
| Employees | 3 | 3 | 4 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.